Healthcare AI Procurement: How to Assess Vendors Without Getting Burned

Author: Eunoia Consulting Co. | Published: July 17, 2026

Healthcare AI procurement is a minefield. Vendors make compelling claims, demonstrations are carefully curated, and the gap between what a product does in a sales environment and what it does in your clinical environment can be enormous. This guide provides a practical framework for assessing AI vendors before you sign.

The Healthcare AI Procurement Problem

Healthcare AI procurement has a trust problem. The market is crowded with vendors making ambitious claims — '95% accuracy', 'reduces documentation time by 60%', 'identifies sepsis 6 hours earlier' — that are often based on research conducted in controlled environments, on curated datasets, by teams with a financial interest in positive results.

The consequences of a poor AI procurement decision in healthcare are not just financial. A clinical decision support tool that performs poorly in your patient population can contribute to adverse outcomes. An administrative AI tool that fails to integrate with your EHR can create workflow chaos. A vendor that is acquired or goes out of business mid-contract can leave you with a critical dependency and no support.

This guide provides a practical framework for assessing healthcare AI vendors — the questions to ask, the evidence to demand, the contract provisions to require, and the red flags that should make you walk away.

The Five Dimensions of Vendor Assessment

1. Clinical Evidence

The most important question in any healthcare AI procurement is: does this tool actually work, in populations like mine, in environments like mine?

Vendors will typically provide you with peer-reviewed publications, white papers, and case studies. These are a starting point, not a conclusion. Before accepting any performance claim, ask:

• Where was the evidence generated? Research conducted at a single academic medical centre may not generalise to a community hospital or a private practice. Ask for evidence from settings similar to yours.
• Who conducted the research? Vendor-sponsored studies have a well-documented tendency to produce more favourable results than independent studies. Require at least one independent validation study.
• What was the comparison? A tool that performs better than 'no tool' is not necessarily better than your current standard of care. Ask for head-to-head comparisons with the alternatives you are actually considering.
• How recent is the evidence? AI models can degrade over time as the data environment changes. Evidence that is more than two years old may not reflect current performance.
• What are the failure modes? Ask specifically about cases where the tool performs poorly. A vendor that cannot describe their tool's failure modes has either not studied them or is not being transparent.

2. Technical Architecture

Understanding how an AI tool works is essential for assessing its suitability for your environment. Key questions include:

• What data does the tool require? Assess whether you can reliably provide the required data in the required format and at the required latency.
• How does the tool integrate with your existing systems? Require a detailed integration specification and references from organisations using the same EHR system as yours.
• Where is data processed? On-premises, cloud-based, or hybrid? What are the implications for data sovereignty and privacy compliance?
• How is the model updated? What is the vendor's process for retraining and deploying model updates? How are you notified of changes that might affect performance?
• What happens when the tool is unavailable? What is the vendor's SLA for uptime, and what is the clinical workflow fallback when the tool is down?

3. Regulatory Status

For AI tools that meet the definition of Software as a Medical Device (SaMD), regulatory clearance or approval is a prerequisite for deployment. Key questions:

• What is the regulatory status of this tool in the jurisdictions where I operate? FDA clearance (510(k) or De Novo), CE marking under the EU MDR/IVDR, or TGA registration as appropriate.
• What is the intended use statement? The regulatory clearance applies to a specific intended use — ensure your planned use falls within that scope.
• How does the vendor manage regulatory changes? The EU AI Act and other emerging regulations may impose new requirements on tools that are already deployed.

4. Data Governance and Security

Healthcare AI tools process sensitive patient data. Your data governance assessment should cover:

• What data does the vendor retain? Audio recordings, patient records, clinical notes — understand exactly what is retained, for how long, and for what purposes.
• Does the vendor use patient data to train their models? If so, is this disclosed to patients and covered by your data processing agreements?
• What security certifications does the vendor hold? SOC 2 Type II, ISO 27001, HITRUST — and are these certifications current?
• What is the vendor's breach notification process? How quickly will they notify you of a data breach, and what support will they provide?

5. Commercial Terms

AI tool contracts require specific provisions that standard software procurement contracts do not include:

| Provision | Why It Matters | |---|---| | Performance warranty with defined metrics | Gives you contractual recourse if the tool does not perform as claimed | | Audit rights | Allows you to verify vendor claims about data practices and model performance | | Incident notification requirements | Ensures you are informed promptly of any events that affect patient safety or data security | | Model change notification | Requires advance notice before the vendor deploys a model update that could affect performance | | Data portability and deletion | Ensures you can retrieve your data and require its deletion if you terminate the contract | | Termination for cause | Allows you to exit the contract if the vendor fails to meet defined performance standards |

The Proof-of-Concept Imperative

No amount of vendor-provided evidence is a substitute for testing the tool in your own environment, with your own data, before committing to a full deployment. A structured proof-of-concept (PoC) is the most reliable way to assess whether an AI tool will perform as claimed.

A well-designed PoC should:

• Run for a minimum of 90 days to capture sufficient data for meaningful analysis
• Use a representative sample of your patient population and case mix
• Measure the specific performance metrics that matter for your use case
• Include a shadow mode phase (the tool runs in parallel with existing workflows without influencing clinical decisions) before a live phase
• Have defined success criteria that are agreed with the vendor before the PoC begins

Red Flags That Should Make You Walk Away

• The vendor cannot provide independent validation evidence from a setting similar to yours
• The vendor refuses to agree to a structured PoC before full deployment
• The vendor cannot describe the failure modes of their tool
• The vendor's contract does not include performance warranties, audit rights, or incident notification requirements
• The vendor is unable to provide references from organisations using the same EHR system as yours
• The vendor's financial position is uncertain (recent funding rounds at significantly reduced valuations, key executive departures, or public reports of financial difficulty)

Total Cost of Ownership

The licence fee is rarely the largest cost of deploying a healthcare AI tool. Before committing to a procurement, build a comprehensive total cost of ownership model that includes:

• Integration costs (EHR integration, data pipeline development, testing)
• Validation costs (clinical validation study, bias audit, regulatory review)
• Training costs (staff training, change management, workflow redesign)
• Ongoing monitoring costs (performance dashboards, clinical review, incident management)
• Vendor management costs (contract management, performance reviews, renewal negotiations)

In our experience, the total cost of ownership for a healthcare AI tool is typically 2–3x the annual licence fee. Organisations that budget only for the licence fee are consistently surprised by the true cost of deployment.

Conclusion

Healthcare AI procurement is one of the highest-stakes purchasing decisions a healthcare organisation makes. The tools you deploy will influence clinical decisions, process patient data, and shape the experience of your staff and patients. Getting it right requires rigour, scepticism, and a willingness to invest the time and resources in proper assessment.

Eunoia Consulting Co. provides independent AI vendor assessment services for healthcare organisations. Contact us to discuss how we can support your procurement process.